Several common infections, including staph, pneumonia, salmonella, sexually transmitted gonorrhea and C. diff can involve drug-resistant bacteria, the agency says.

FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together.

Last summer, the Food and Drug Administration denied an application for a new antifungal drug called olorofim, sending it back to the company with a request for more data. If approved, it would ...

Infections from the drug-resistant Shigella bacteria, often resulting in severe diarrhea and stomach pain, have been climbing at an alarming rate, too. In February, ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

People with drug use-associated infective endocarditis are at high risk of mortality and future hospitalization for bacterial infections, including endocarditis, skin and soft tissue infections ...

An international team of researchers led by Konstanz biologists has identified a molecular mechanism that regulates the activity of ...

Respiratory syncytial virus infection (RSV) is an illness that affects the lungs and breathing passages. It typically resolves without medication. However, if the condition is severe, medications ...

The study, published Sept. 30 in Open Forum Infectious Diseases, analyzed 45,049 patient records from 779 hospitals of adults who received treatment for C. diff infections before and after 2021.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a newer type of medication used to help people with diabetes manage ...